TransEnterix (NYSEMKT: TRXC)recently surprised investors on the upside when it reported its first-quarter results. The company's Senhance surgical system is off to a fast start right out of the gate, and it has attracted a lot of positive attention from the medical community. This just goes to show how much demand is out there for an alternativeto Intuitive Surgical's (NASDAQ: ISRG)dominant da Vinciplatform.
5 Must-Read Quotes From TransEnterix's Big First Quarter
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться